Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis.
about
Rho kinase as a target for cerebral vascular disordersStrategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation.Genetic variation in the functional ENG allele inherited from the non-affected parent associates with presence of pulmonary arteriovenous malformation in hereditary hemorrhagic telangiectasia 1 (HHT1) and may influence expression of PTPN14Genetics of cerebral cavernous malformations: current status and future prospectsVascular permeability in cerebral cavernous malformations.Introduction to cerebral cavernous malformation: a brief review.Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations.Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel.Constitutional de novo and postzygotic mutations in isolated cases of cerebral cavernous malformationsFAM222B Is Not a Likely Novel Candidate Gene for Cerebral Cavernous Malformations.Endothelial chromosome 13 deletion in congenital heart disease-associated pulmonary arterial hypertension dysregulates SMAD9 signaling.Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations.Nuclear Localization of Integrin Cytoplasmic Domain-associated Protein-1 (ICAP1) Influences β1 Integrin Activation and Recruits Krev/Interaction Trapped-1 (KRIT1) to the Nucleus.Novel loss of function mutation in KRIT1/CCM1 is associated with distinctly progressive cerebral and spinal cavernous malformations after radiochemotherapy for intracranial malignant germ cell tumor.Cerebral Cavernous Malformations: An Update on Prevalence, Molecular Genetic Analyses, and Genetic Counselling
P2860
Q28081507-2D07EC3E-B688-493E-A49F-983A5F532312Q35167117-47734A9E-B890-4181-B79E-60405448E674Q35170438-762D1059-749E-4903-BA1A-8C58EFE5ACCEQ35706117-C39BE46A-CF4E-49D8-9202-67E5DF9E2ED4Q36267403-02B6D7C9-CC12-4507-B898-5309515572DDQ37351147-1E4D142B-3839-43BA-BF0A-BCB04CE334DEQ38640436-B9C9F44B-069F-4A18-B170-C97398AE579EQ38848129-D419103F-D0CC-4551-8168-3130043CDC70Q39003079-8777C6F5-5B6D-48A0-ACD3-429D538C8718Q41716411-1E520470-F285-48E2-9BE1-FA660D008156Q42592424-C64AC5BB-9C84-4D9A-AEC1-177A33ABC6A1Q46147842-DD5684ED-1349-4C45-8098-9821D85EBE3DQ48127718-78F04D11-71B4-43AA-AA66-26FAE8C3565EQ48167145-A5D96559-2083-43B6-9075-1610FEAD10FDQ57652948-9D1A9937-2AEC-4374-A6BD-B5A051F5FEB6
P2860
Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Lesions from patients with spo ...... pathway for CCM pathogenesis.
@ast
Lesions from patients with spo ...... pathway for CCM pathogenesis.
@en
type
label
Lesions from patients with spo ...... pathway for CCM pathogenesis.
@ast
Lesions from patients with spo ...... pathway for CCM pathogenesis.
@en
prefLabel
Lesions from patients with spo ...... pathway for CCM pathogenesis.
@ast
Lesions from patients with spo ...... pathway for CCM pathogenesis.
@en
P2093
P2860
P356
P1476
Lesions from patients with spo ...... l pathway for CCM pathogenesis
@en
P2093
Amy L Akers
Carol J Gallione
Changbin Shi
Douglas A Marchuk
Issam A Awad
Michel J Berg
Nicholas De Castro
Robert Shenkar
Stephanie Li
P2860
P304
P356
10.1093/HMG/DDU153
P577
2014-04-03T00:00:00Z